BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Cofilin 1 (CFL1); SH3 and multiple ankyrin repeat domains 3 (SHANK3; PROSAP2; SPANK-2)

June 4, 2015 7:00 AM UTC

Mouse studies suggest CFL1 inhibitors could help treat autism. CFL1 is involved in actin depolymerization and mutations in SHANK3 and other actin regulators are associated with risk of autism. In the ...